These findings all suggest that the intermediate-length expansions in Atx2 enhance TDP-43 proteinopathies and worsen the degenerative phenotypes, thereby increasing the susceptibility to ALS or FTLD. The gene discussed is ATXN2; the disease is amyotrophic lateral sclerosis.